Which therapeutic option has been found beneficial for patients with Gaucher type 1 disease?

Question

Quizplus · Accepted Answer

Enzyme-replacement therapy with imiglucerase (Cerezyme), which is infused intravenously every 2 weeks once a blood level has been achieved, can reduce liver size, spleen size, and bone pain within a few weeks of beginning the therapy, although each patient's response is variable. It is one of three drugs used for enzyme-replacement therapy in Gaucher type 1. The other two drugs are taliglucerase (ELELYSO), and velaglucerase (VPRIV),

Which Therapeutic Option Has Been Found Beneficial for Patients with Gaucher